Marijuana Research Today is a free monthly online journal that collates and summarizes the latest research about Marijuana, including details on benefits, cancer, effects, uses, addiction.

Volume 6 (2009), Issue 3 (March)

1. Risk factors for young adult substance use among women who were teenage mothers.
   Addict Behav, 34(5): 463-70. [Abstract] [Full-text]
2. Alcohol criteria endorsement and psychiatric and drug use disorders among DUI offenders: greater severity among women and multiple offenders.
   Addict Behav, 34(5): 432-9. [Abstract] [Full-text]
3. Tests of causal links between alcohol abuse or dependence and major depression.
   Arch Gen Psychiatry, 66(3): 260-6. [Abstract] [Full-text]
4. Alcohol use before and during pregnancy in western Washington, 1989-2004: implications for the prevention of fetal alcohol spectrum disorders.
   Am J Obstet Gynecol, 200(3): 278.e1-8. [Abstract] [Full-text]
5. Associations between substance use, erectile dysfunction medication and recent HIV infection among men who have sex with men.
   AIDS Behav, 13(2): 328-36. [Abstract] [Full-text]
6. Toxicology and circumstances of completed suicide by means other than overdose.
   J Forensic Sci, 54(2): 490-4. [Abstract] [Full-text]
7. Do cannabinoids have a role in cancer pain management?
   Curr Opin Support Palliat Care, 3(1): 7-13. [Abstract] [Full-text]
8. Are cannabis users who participate in a randomized clinical trial different from other treatment seekers?
   J Subst Abuse Treat, 36(3): 339-44. [Abstract] [Full-text]
9. Association of marijuana use and the incidence of testicular germ cell tumors.
   Cancer, 115(6): 1215-23. [Abstract] [Full-text]
10. Brief intervention addressing excessive cannabis use in young people consulting their GP: a pilot study.
    Br J Gen Pract, 59(560): 166-72. [Abstract] [Full-text]
11. Apparent affinity estimates of rimonabant in combination with anandamide and chemical analogs of anandamide in rhesus monkeys discriminating Delta(9)-tetrahydrocannabinol.
    Psychopharmacology (Berl), 203(2): 219-28. [Abstract] [Full-text]
12. Substitution profile of Delta(9)-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in humans discriminating Delta(9)-tetrahydrocannabinol.
    Psychopharmacology (Berl), 203(2): 241-50. [Abstract] [Full-text]
13. Early outcomes following low dose naltrexone enhancement of opioid detoxification.
    Am J Addict, 18(2): 109-16. [Abstract] [Full-text]
14. Driving under the influence of drugs and alcohol in Salzburg and Upper Austria during the years 2003-2007.
    Leg Med (Tokyo). [Abstract] [Full-text]
15. Hypogonadism in men receiving methadone and buprenorphine maintenance treatment.
    Int J Androl, 32(2): 131-9. [Abstract] [Full-text]
16. Fatal all-terrain vehicle crashes: injury types and alcohol use.
    Am J Prev Med, 36(4): 311-6. [Abstract] [Full-text]
17. Substance use and delinquency among fifth graders who have jobs.
    Am J Prev Med, 36(4): 297-303. [Abstract] [Full-text]
18. Detrimental psychophysiological effects of early maternal deprivation in adolescent and adult rodents: altered responses to cannabinoid exposure.
    Neurosci Biobehav Rev, 33(4): 498-507. [Abstract] [Full-text]
19. Substance use among women: associations with pregnancy, parenting, and race/ethnicity.
    Matern Child Health J, 13(3): 376-85. [Abstract] [Full-text]
20. Intermediate cannabis dependence phenotypes and the FAAH C385A variant: an exploratory analysis.
    Psychopharmacology (Berl), 203(3): 511-7. [Abstract] [Full-text]
21. Disclosure of sexual orientation and subsequent substance use and abuse among lesbian, gay, and bisexual youths: Critical role of disclosure reactions.
    Psychol Addict Behav, 23(1): 175-84. [Abstract] [Full-text]
22. Correlates of gambling among youth in an inner-city emergency department.
    Psychol Addict Behav, 23(1): 113-21. [Abstract] [Full-text]
23. Gz mediates the long-lasting desensitization of brain CB1 receptors and is essential for cross-tolerance with morphine.
    Mol Pain, 5: 11. [Abstract] [Full-text]
24. Modulation of excitatory synaptic transmission by Delta 9-tetrahydrocannabinol switches from agonist to antagonist depending on firing rate.
    Mol Pharmacol, 75(4): 892-900. [Abstract] [Full-text]
25. Substance use and behaviour disorders in Puerto Rican youth: a migrant family study.
    J Epidemiol Community Health, 63(4): 310-6. [Abstract] [Full-text]
26. Health risk behaviors in relation to making a smoking quit attempt among adolescents.
    J Behav Med, 32(2): 142-9. [Abstract] [Full-text]
27. Simultaneous ultra-high-pressure liquid chromatography-tandem mass spectrometry determination of amphetamine and amphetamine-like stimulants, cocaine and its metabolites, and a cannabis metabolite in surface water and urban wastewater.
    J Chromatogr A, 1216(15): 3078-89. [Abstract] [Full-text]
28. Sexual partner characteristics and sexually transmitted diseases among adolescents and young adults.
    Sex Transm Dis, 36(4): 232-8. [Abstract] [Full-text]
29. Media Exposure and Marijuana and Alcohol Use Among Adolescents.
    Subst Use Misuse. [Abstract] [Full-text]
30. A preliminary study of the population-adjusted effectiveness of substance abuse prevention programming: towards making IOM program types comparable.
    J Prim Prev, 30(2): 89-107. [Abstract] [Full-text]
31. Current trends in drug abuse associated fatalities - Jordan, 2000-2004.
    Forensic Sci Int, 186(1): 44-7. [Abstract] [Full-text]
32. Nonmedical use of prescription medications: an emerging risk behavior among rural adolescents.
    J Adolesc Health, 44(4): 407-9. [Abstract] [Full-text]
33. Nonadherence to primary prophylaxis against Pneumocystis jirovecii pneumonia.
    PLoS ONE, 4(3): e5002. [Abstract] [Full-text]
34. Onset and lifetime use of drugs in New Zealand: Results from Te Rau Hinengaro: The New Zealand Mental Health Survey 2003-2004.
    Drug Alcohol Rev, 28(2): 166-174. [Abstract] [Full-text]
35. Is socioeconomic status in early life associated with drug use? A systematic review of the evidence.
    Drug Alcohol Rev, 28(2): 142-53. [Abstract] [Full-text]
36. It ain't what you do, it's the way that you do it: A qualitative study of advice for young cannabis users.
    Drug Alcohol Rev, 28(2): 129-34. [Abstract] [Full-text]
37. Views of Australian mental health stakeholders on clients' problematic drug and alcohol use.
    Drug Alcohol Rev, 28(2): 122-8. [Abstract] [Full-text]
38. Challenges in reducing cannabis-related harm in Australia.
    Drug Alcohol Rev, 28(2): 110-6. [Abstract] [Full-text]
39. The interactive effect of anxiety sensitivity and frequency of marijuana use in terms of anxious responding to bodily sensations among youth.
    Psychiatry Res, 166(2): 238-46. [Abstract] [Full-text]
40. The effects of cannabinoids on serum cortisol and prolactin in humans.
    Psychopharmacology (Berl), 203(4): 737-44. [Abstract] [Full-text]
41. Joint use of drugs and alcohol.
    Eur Addict Res, 15(2): 113-20. [Abstract] [Full-text]
42. Pot paresis: marijuana and a case of hypokalemic periodic paralysis.
    J Emerg Med, 36(3): 236-8. [Abstract] [Full-text]
43. Traffic risk behaviors at nightlife: drinking, taking drugs, driving, and use of public transport by young people.
    Traffic Inj Prev, 10(2): 162-9. [Abstract] [Full-text]

© 2004-2010 Marijuana Research Today. All Rights Reserved.